Glatiramer Acetate
NDC 82983-430, glatiramer acetate, injection, solution, from AJENAT PHARMACEUTICALS LLC.
- Product NDC
- 82983-430
- Status
- Listed
- Labeler
- AJENAT PHARMACEUTICALS LLC
- Dosage form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA214022
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/82983-430 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- GLATIRAMER ACETATE40 mg/mL
| Package NDC | NDC-11 | Package |
|---|---|---|
| 82983-430-12 | 82983043012 | 12 BLISTER PACK in 1 CARTON (82983-430-12) / 1 SYRINGE in 1 BLISTER PACK (82983-430-01) / 1 mL in 1 SYRINGE |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/1ec10223-880d-402f-a759-9cd179bf09de
Use it
Look up 82983-430 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/82983-430 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 82983-430. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.